The estimated Net Worth of Krishna G. Palepu is at least $1.9 Milion dollars as of 15 November 2007. Krishna Palepu owns over 2,285 units of Brooks Automation stock worth over $1,672,184 and over the last 19 years he sold BRKS stock worth over $0. In addition, he makes $225,022 as Independent Director at Brooks Automation.
Krishna has made over 1 trades of the Brooks Automation stock since 2007, according to the Form 4 filled with the SEC. Most recently he bought 2,285 units of BRKS stock worth $31,487 on 15 November 2007.
The largest trade he's ever made was buying 2,285 units of Brooks Automation stock on 15 November 2007 worth over $31,487. On average, Krishna trades about 127 units every 0 days since 2005. As of 15 November 2007 he still owns at least 14,785 units of Brooks Automation stock.
You can see the complete history of Krishna Palepu stock trades at the bottom of the page.
Prof. Dr. Krishna G. Palepu serves as Independent Director of the company. Professor Palepu is the Ross Graham Walker Professor of Business Administration and senior advisor to the president of Harvard University on global strategy. Among his other responsibilities at Harvard Business School, Professor Palepu teaches in several different corporate governance educational programs. Prior to assuming his current administrative position, Professor Palepu held other positions at Harvard Business School, including Senior Associate Dean for International Development and Senior Associate Dean for Research. Professor Palepu was formerly a member of the board of directors of Dr. Reddy’s Laboratories Ltd., an Indian global pharmaceuticals company, from 2002 until 2009, and PolyMedica Corp, a Massachusetts provider of diabetes testing supplies and products, from June 2006 until it was sold in August 2007. Professor Palepu also serves as a trustee of The Winsor School. Professor Palepu was also formerly a member of the board of directors of BTM Corporation, a privately-owned management solutions provider focused on converging business with technology, and Satyam Computer Services Limited (“Satyam”), an Indian company whose shares were publicly traded in India and on the New York Stock Exchange. In December 2008, Professor Palepu resigned from the board of Satyam. Following his resignation, Satyam has been the subject of significant litigation, a portion of which has included Professor Palepu as a named defendant. For a full discussion of the Satyam litigation as it relates to Professor Palepu, please see the section titled “Pending Legal Matters” below. Professor Palepu holds a Master Professional Director Certification from the American College of Corporate Directors.
As the Independent Director of Brooks Automation, the total compensation of Krishna Palepu at Brooks Automation is $225,022. There are 12 executives at Brooks Automation getting paid more, with Stephen Schwartz having the highest compensation of $3,971,410.
Krishna Palepu is 65, he's been the Independent Director of Brooks Automation since 2005. There are 9 older and 15 younger executives at Brooks Automation. The oldest executive at Brooks Automation, Inc. is A. Clinton Allen, 76, who is the Independent Director.
Krishna's mailing address filed with the SEC is C/O BROOKS AUTOMATION, INC., 15 ELIZABETH DRIVE, CHELMSFORD, MA, 01824.
Over the last 21 years, insiders at Brooks Automation have traded over $110,337,278 worth of Brooks Automation stock and bought 84,885 units worth $755,883 . The most active insiders traders include Stephen S Schwartz, Amin J Khoury a A Clinton Allen. On average, Brooks Automation executives and independent directors trade stock every 22 days with the average trade being worth of $1,392,261. The most recent stock trade was executed by David Jarzynka on 19 November 2021, trading 10,216 units of BRKS stock currently worth $1,228,883.
Brooks Automation Inc. is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europeand Asia.
Brooks Automation executives and other stock owners filed with the SEC include: